- Home
- SSTI vs ACHV Comparison
SSTI vs ACHV Comparison
Compare SSTI & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSTI
- ACHV
- Stock Information
- Founded
- SSTI 1996
- ACHV N/A
- Country
- SSTI United States
- ACHV United States
- Employees
- SSTI N/A
- ACHV N/A
- Industry
- SSTI Computer Software: Prepackaged Software
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SSTI Technology
- ACHV Health Care
- Exchange
- SSTI Nasdaq
- ACHV Nasdaq
- Market Cap
- SSTI 145.1M
- ACHV 167.6M
- IPO Year
- SSTI 2017
- ACHV N/A
- Fundamental
- Price
- SSTI $10.89
- ACHV $5.12
- Analyst Decision
- SSTI Buy
- ACHV Strong Buy
- Analyst Count
- SSTI 7
- ACHV 1
- Target Price
- SSTI $20.29
- ACHV $12.00
- AVG Volume (30 Days)
- SSTI 63.0K
- ACHV 2.2M
- Earning Date
- SSTI 11-12-2025
- ACHV 11-06-2025
- Dividend Yield
- SSTI N/A
- ACHV N/A
- EPS Growth
- SSTI N/A
- ACHV N/A
- EPS
- SSTI N/A
- ACHV N/A
- Revenue
- SSTI $103,899,000.00
- ACHV N/A
- Revenue This Year
- SSTI $11.17
- ACHV N/A
- Revenue Next Year
- SSTI $9.39
- ACHV N/A
- P/E Ratio
- SSTI N/A
- ACHV N/A
- Revenue Growth
- SSTI 1.47
- ACHV N/A
- 52 Week Low
- SSTI $9.33
- ACHV $1.84
- 52 Week High
- SSTI $19.43
- ACHV $5.78
- Technical
- Relative Strength Index (RSI)
- SSTI 35.14
- ACHV 82.82
- Support Level
- SSTI $11.01
- ACHV $3.06
- Resistance Level
- SSTI $11.56
- ACHV $5.78
- Average True Range (ATR)
- SSTI 0.38
- ACHV 0.31
- MACD
- SSTI -0.07
- ACHV 0.22
- Stochastic Oscillator
- SSTI 2.52
- ACHV 76.00
About SSTI SoundThinking Inc.
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.